First Time Loading...

Centogene NV
NASDAQ:CNTG

Watchlist Manager
Centogene NV Logo
Centogene NV
NASDAQ:CNTG
Watchlist
Price: 0.4889 USD 1.88% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

CNTG Price Targets Summary
Centogene NV

Wall Street analysts forecast CNTG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTG is 1.53 USD with a low forecast of 1.515 USD and a high forecast of 1.575 USD.

CNTG Lowest Forecast
Wall Street Target
1.515 USD
210% Upside
CNTG Average Forecast
Wall Street Target
1.53 USD
213% Upside
CNTG Highest Forecast
Wall Street Target
1.575 USD
222% Upside
Lowest
Price Target
1.515 USD
210% Upside
Average
Price Target
1.53 USD
213% Upside
Highest
Price Target
1.575 USD
222% Upside
Centogene NV Competitors:
Price Targets
1672
Ascletis Pharma Inc
127% Upside
PBYI
Puma Biotechnology Inc
12% Downside
IRWD
Ironwood Pharmaceuticals Inc
135% Upside
SERA
Sera Prognostics Inc
74% Downside
1672
Ascletis Pharma Inc
127% Upside
PBYI
Puma Biotechnology Inc
12% Downside
IRWD
Ironwood Pharmaceuticals Inc
135% Upside
SERA
Sera Prognostics Inc
74% Downside
CYTH
Cyclo Therapeutics Inc
224% Upside
ABBV
Abbvie Inc
18% Upside
HOOK
HOOKIPA Pharma Inc
437% Upside
RNA
Avidity Biosciences Inc
96% Upside

Revenue
Forecast

Revenue Estimate
Centogene NV

For the last 5 years the compound annual growth rate for Centogene NV's revenue is 8%. The projected CAGR for the next 2 years is 13%.

8%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-32%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Centogene NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Centogene NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
What are analyst estimates?

See Also

Summary
CNTG intrinsic value, competitors valuation, and company profile.
DCF Valuation
CNTG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CNTG stock valuation using valuation multiples.
Wall Street Estimates
CNTG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CNTG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CNTG's stock price target?
Price Target
1.53 USD

According to Wall Street analysts, the average 1-year price target for CNTG is 1.53 USD with a low forecast of 1.515 USD and a high forecast of 1.575 USD.

What is Centogene NV's Revenue forecast?
Projected CAGR
13%

For the last 5 years the compound annual growth rate for Centogene NV's revenue is 8%. The projected CAGR for the next 2 years is 13%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.